期刊文献+

前列腺癌与良性前列腺增生的临床病理与免疫组化分析 被引量:2

下载PDF
导出
摘要 目的对前列腺癌和良性前列腺增生的病理形态学及免疫组化进行分析,以提高对前列腺癌的诊断准确率。方法回顾性分析我院2007年1月至2009年10月间送检病理的39例前列腺癌患者及同期92例良性前列腺增生患者的临床资料,将其病理学形态及免疫组化特点进行比较分析。结果前列腺癌39例,表现为正常大腺泡结消失、基底细胞消失、组织结构异常、核间变和间质浸润等形态学改变;免疫组化显示p504s阳性率97.5%,p63均阴性,CK34βE12局灶阳性率2.5%。而良性前列腺增生92例,存在基底细胞层,仅偶见少数腺上皮细胞核仁增大;免疫组化显示CK34βE12和p63均阳性,p504s局灶弱阳性率5%。前列腺癌和良性前列腺增生PSA血清学检测值对照,两者具有显著差异(P<0.05)。结论结合临床资料、病理形态学改变及免疫组化指标进行综合分析,对提高前列腺癌诊断和鉴别诊断的准确率很有帮助。
作者 周伟平
出处 《中外医疗》 2010年第15期34-35,共2页 China & Foreign Medical Treatment
  • 相关文献

参考文献9

  • 1William GN,Angclo MD,Wiliam BL.Prostate Cancer[J].New England J Medicine,2003,349(4):366-381.
  • 2Totton Rs,Heine mann MW,Hudson PB,et al.Microscopic differential diagnosis of latent carcinoma of the prostate[J].Arch Pathol,1953.55:131-141.
  • 3陈洁晴,蒋智铭,张惠箴,刘亮,周健华.前列腺穿刺活检中核仁的形态学测量及其诊断意义[J].诊断病理学杂志,2003,10(3):144-146. 被引量:10
  • 4Shah RB,Zhou M,LeBlanc M,et al.Comparsion of basal cellspecific markers,34 β E12 and p63,in diagnosis of prostate canecr[J].Am J Surg Pathol,2002,26(9):1161-1168.
  • 5Xu J,Stolk JA,Zhang X,et al.Identificaion of differentially expressed genes in human porstate cancer using subtraction and microarter[J].Cancer Res,2000,60:1677-1682.
  • 6Jjang Z,Woda BA,Rock KL,et al.P504s:a new molecular marker for the detection of prostate carcinoma[J].Am J Surg Pathol,2001,25:1397-1404.
  • 7Luo J,Zha S,Gage WR,et al.Alpha-miethylacy-Co A racemase:a new molecclar marker for prostate cancer[J].Cancer Res,2002,62:2220-2226.
  • 8Rubin MA,Zhou M,Dhanasekaran SM,et al.Alapha-methylacyl coenzyme A racemase as a marker for prostate cancer[J].JAMA,2002,287(13):1662-1670.
  • 9陈洁晴,蒋智铭,张惠箴,周健华,刘亮.免疫组化在前列腺穿刺活检中的诊断价值[J].诊断病理学杂志,2002,9(2):70-72. 被引量:6

二级参考文献12

  • 1[1]Buhmeida A,Kujari H,Collan Y.Necleolar morphometry in fine needle aspiration biopsies of the prostate.Anal Quant Histol,2001,23:185
  • 2[2]Kramer CE,Epstein JI.Nucleoli in low-grade prostate adenocarcinoma and adenosis.Hum Pathol,1993,24:618
  • 3[3]Kelemen PR,Buschmann RJ,Weisz Carrington P.Necleolar prominence as a diagnostic variable in prostatic carcinoma.Cancer,1990,65:1017
  • 4Gaudin PB,Reuter VE.Benign mimics of prostatic adenocarcinoma on needle biopsy.Anatonsic pathol,1997,2:111
  • 5Randolph TL,Amin MB,Ro JY,et al.Histologic variants of adenocarcinoma and other carcinomas of prostate:pathologic crteria and clinical significance.Mod Pathol,1997,10:612
  • 6Brinker DA,Potter SR,Epstein JI.Ductal adenocarcinoma of the prostate diagnosed on needle biopsy.Am J Surg Pathol,1999,23:1471
  • 7Epstein JI,Wojno KJ.The prostate and seminal vesicles.diagnostic surgical pathology.Third edition.Stemberg SS:Lippincott Williams,& W ilkins,Philadelphia ,1999.1893
  • 8Rubin MA,Bassilv N,Sanda M,et al.Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma.Am J Surg Pathol,2000,24:183
  • 9张惠箴,蒋智铭,陈洁晴,周健华,卞国伟,刘亮.前列腺间质肉瘤──一种由特异性间质细胞发生的肿瘤[J].老年医学与保健,2000,6(2):70-71. 被引量:5
  • 10蒋智铭,张惠箴,陈洁晴,周健华,刘亮,卞国伟,周永昌,陈亚青.穿刺活检100例前列腺癌的形态学观察[J].中华病理学杂志,2000,29(4):272-275. 被引量:17

共引文献13

同被引文献22

  • 1赖建生,夏强,张孝斌,赵国平,许胜利,郑东升.增殖细胞核抗原和p27在前列腺增生和前列腺癌组织中的表达及意义[J].中华肿瘤杂志,2004,26(8):476-478. 被引量:13
  • 2余涛,朱绍兴.AMACR(P504S)在前列腺癌诊断中的应用进展[J].国际泌尿系统杂志,2006,26(5):616-621. 被引量:3
  • 3姜众,马珂.AMACR/P504S的发现及其在前列腺癌诊断中应用[J].临床与实验病理学杂志,2007,23(3):262-265. 被引量:5
  • 4刘修恒.前列腺癌的早期诊断[J].临床泌尿外科杂志,2007,22(7):482-485. 被引量:6
  • 5Jiang Z, Woaa BA, Wu CL, et al. Discovery and clinical applica- tion of a novel prostate cancer alphane thy Lacyl CoA racem ase (PS04s) [J]. Am J Clin pathol,2004,122(2) :275-289.
  • 6Ophir J, Cespedes I, Ponnekanti H, et al. Elastogra phy: a quantitative method for imaging the elasticity of biologicaltissues[Jj. UhrasonImaging, 1991, 13:111 -134.
  • 7Kamoi K, Okihara K, Ochiai A, et al. The utility oftransrectal real-time elastography in the diagnosis of prostate cancer[J]. Ultrasound Med Biol, 2008, 34: 1025-1032.
  • 8杜广,袁维祥,李东,等.前列腺增生和前列腺癌患者血、尿中PSA糖链结构的改变及意义[J].中围男科学杂志,2008,22(6):33-35.
  • 9Luciani L G, De Giorgi G, Valotto C, et al. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/ml and abnormal digital rectal examination findings[J]. U- rology, 2006, 67: 555-558.
  • 10Aigner F, Pallwein L, Junker D, et al. Value of real- time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ ml or greater and 4.00 ng/ml or less[J]. J Urol, 2010, 184: 913-917.

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部